Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus

Diabetes Metab Rev. 1993 Nov:9 Suppl 1:35S-41S. doi: 10.1002/dmr.5610090507.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Double-Blind Method
  • Fatty Acids, Nonesterified / blood
  • Fenfluramine / analogs & derivatives*
  • Fenfluramine / therapeutic use
  • Gluconeogenesis / drug effects
  • Glucose Clamp Technique
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / blood
  • Lactates / blood
  • Liver / drug effects
  • Liver / metabolism
  • Middle Aged

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Hypoglycemic Agents
  • Insulin
  • Lactates
  • Fenfluramine
  • benfluorex